feels early to me for quarter end window dressing but who knows
i will say the volume hasn't been impressive. yes, i it has increased vs. previous historic. but even today, didnt even do $500k. this isn't big boys. just not enough dollars. need a lot mroe days like today. and to john's point, it really doesnt take much of an investment to force this thing up / window dressing
but at least going up
I need to look at closer at when i have more time .... but where do you see pfizer has ROFR on acquisiton. I see colloboration, licensing, and co marketing.
is that seeking alpha guy the same person as the chilean twitter guy?
it is a right of first refusal. . what happens if lpath or successor company chooses not to partner at all. keep it all internal. i think they have that option.
I think you are understating what a CEO with industry credibility, connections, and experience can bring to the table. This is a tiny company. One person can make a difference